We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.

1mmv

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1mmv.gif|left|200px]]
+
{{Seed}}
 +
[[Image:1mmv.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1mmv| PDB=1mmv | SCENE= }}
{{STRUCTURE_1mmv| PDB=1mmv | SCENE= }}
-
'''Rat neuronal NOS heme domain with NG-propyl-L-arginine bound'''
+
===Rat neuronal NOS heme domain with NG-propyl-L-arginine bound===
-
==Overview==
+
<!--
-
Isoform-specific nitric-oxide synthase (NOS) inhibitors may prove clinically useful in reducing the pathophysiological effects associated with increased neuronal NOS (nNOS) or inducible NOS (iNOS) activity in a variety of neurological and inflammatory disorders. Analogs of the NOS substrate L-arginine are pharmacologically attractive inhibitors because of their stability, reliable cell uptake, and good selectivity for NOS over other heme proteins. Some inhibitory arginine analogs show significant isoform selectivity although the structural or mechanistic basis of such selectivity is generally poorly understood. In the present studies, we determined by x-ray crystallography the binding interactions between rat nNOS and N5-(1-imino-3-butenyl)-L-ornithine (L-VNIO), a previously identified mechanism-based, irreversible inactivator with moderate nNOS selectivity. We have also synthesized and mechanistically characterized several L-VNIO analogs and find, surprisingly, that even relatively minor structural changes produce inhibitors that are either iNOS-selective or non-selective. Furthermore, derivatives having a methyl group added to the butenyl moiety of L-VNIO and L-VNIO derivatives that are analogs of homoarginine rather than arginine display slow-on, slow-off kinetics rather than irreversible inactivation. These results elucidate some of the structural requirements for isoform-selective inhibition by L-VNIO and its related alkyl- and alkenyl-imino ornithine and lysine derivatives and may provide information useful in the ongoing rational design of isoform-selective inhibitors.
+
The line below this paragraph, {{ABSTRACT_PUBMED_12960153}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 12960153 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_12960153}}
==About this Structure==
==About this Structure==
Line 30: Line 34:
[[Category: Nitric oxide synthase]]
[[Category: Nitric oxide synthase]]
[[Category: Oxydoreductase]]
[[Category: Oxydoreductase]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 01:26:05 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Jul 3 00:24:48 2008''

Revision as of 21:24, 2 July 2008

Image:1mmv.png

Template:STRUCTURE 1mmv

Rat neuronal NOS heme domain with NG-propyl-L-arginine bound

Template:ABSTRACT PUBMED 12960153

About this Structure

1MMV is a Single protein structure of sequence from Rattus norvegicus. Full crystallographic information is available from OCA.

Reference

Structural characterization and kinetics of nitric-oxide synthase inhibition by novel N5-(iminoalkyl)- and N5-(iminoalkenyl)-ornithines., Bretscher LE, Li H, Poulos TL, Griffith OW, J Biol Chem. 2003 Nov 21;278(47):46789-97. Epub 2003 Sep 5. PMID:12960153

Page seeded by OCA on Thu Jul 3 00:24:48 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1mmv"
Personal tools